Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

The course CCBIO905 – Methods in Cancer Biomarker Research was arranged for the fourth time September 27-29, 2022. This was the second time as a fully digital event. From the confusion of the first pandemic months, CCBIO is now highly experienced in organizing digital events, and hybrid events, for that matter. One thing is however clear – it takes a village to run a good online course!
A collaboration project on vulvar cancer between the Bjørge, Costea and Mustafa groups are using a 3D bioprinter to print tiny vulvar cancer tumors with live support tissue, for more realistic testing of which therapy will give the best response.
The McCormack group at CCBIO and the Department of Clinical Science is now launching the EU collaboration project CoDaFlight (Colouring the Dark in Fluorescence light), financed by the EU Pathfinder program. This project has the promise to develop the next generation of medical fluorescence imaging.
The results are out and BCEPS is one of two centres at the University of Bergen to receive Centre of Excellence (SFF) status from the Research Council of Norway.
Flowers and smiles were in abundance when CCBIO, the Department of Clinical Medicine, the Medial Faculty and the Trond Mohn Foundation welcomed Carina Strell to the University of Bergen in a CCBIO Startup Seminar August 25.
Friday June 10th, CCBIO and the Holberg Prize hosted a Special Seminar with the 2022 Holberg Laureate, Sheila Jasanoff (Harvard University) in conversation with Stephen Hilgartner (Cornell University). The seminar was called “Can science make sense of life?”, referring to Jasanoff’s recent and eponymous book. This was the first time the Faculty of Medicine had the opportunity to welcome a Holberg... Read more
The 10th CCBIO Annual Symposium took place at Solstrand Hotel May 10 and 11, 2022, finally as an onsite event, attracting about 200 onsite and 60 online, as the symposium was offered as a hybrid solution.
Researcher and co-founder of the biotech-company Moderna, Robert S. Langer, has met a lot of skepticism and rejection in his career. He explains the road to success with being stubborn, having courage to think big and to have good role-models.
This question is central to the research of the 2022 Holberg Prize winner, Sheila Jasanoff, who has a long-standing collaboration with University of Bergen researchers.
The PhD level course on Health Innovation, CCBIONEUR912, was kicked off November 8-9, 2021, at the facilities of the new medical incubator EITRI. CCBIONEUR912 is joining the course SDG900 as the second innovation course offering at UiB on the PhD level. It is the first PhD course on health innovation and thus an invaluable offering for medical researchers at the beginning of their research... Read more
The Trond Mohn Foundation has now announced that Carina Strell will be one of three candidates at the University of Bergen (UiB) to be awarded with a TMS starting grant, for her project Understanding Early Breast Cancer Evolution in Space and Time (EvoMaps). Strell has a long-term collaboration with the Lars A. Akslen group at CCBIO, and her project will be embedded at CCBIO.
November 9, Professor Robert S. Langer, Massachusetts Institute of Technology, presented the Falch Lecture entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Through a live streaming from MIT, the around 200 people in Store Auditorium enjoyed a truly inspirational talk, motivating them to pursue their ideas and keep asking the fundamental questions.
November 9, Professor Robert S. Langer, Massachusetts Institute of Technology, will present the Falch Lecture at a live streaming from MIT in Store Auditorium entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Dr. Langer has been called "The Edison of Medicine", and he has an exceptional track record in science and innovation.
On October 20, CCBIO hosted a Celebration Seminar to celebrate the awarding of the King Olav V’s Prize for Cancer Research 2021 to Professor Bjørn Tore Gjertsen. Leaders from the university and the hospital as well as close colleagues gave highly praising speeches and scientific talks.
The Norwegian Cancer Society announced September 2nd that this year’s King Olav V's Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen. The award amounts to 1 million NOK, is considered as a great honor in the Norwegian research communities and goes to the very best in the entire spectrum of Norwegian cancer research.
Dana Costea is this year’s receiver of the Pindborg Prize, an annual award issued by The Scandinavian Fellowship of Oral Pathology and Oral Medicine (SFOPOM), in memory of the late Professor Jens J. Pindborg, internationally renowned dentist and pathologist.
A broad range of renowned international cancer scientists gave talks at the 2021 CCBIO Annual Symposium, which for the very first time was held as a fully online event.
CCBIO initiated its research school – CCBIO Research School for Cancer Studies (RSCS) – very early on, and the RSCS has since the startup in 2014 undergone a steady progress and expansion of the course portfolio. Now that CCBIO’s parent department the Department of Clinical Medicine has been assigned an FKB center (Centre for Clinical Treatment Research) – Neuro-SysMed – CCBIO is happy to be able... Read more

Pages